Medical Properties Trust, Inc. (NYSE:MPW) issued an update on its FY17 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $1.29-1.31 for the period, compared to the Thomson Reuters consensus estimate of $1.33. Medical Properties Trust also updated its FY18 guidance to $1.42-1.46 EPS.
Shares of Medical Properties Trust, Inc. (MPW) traded down 0.79% during mid-day trading on Friday, hitting $12.51. The stock had a trading volume of 2,378,049 shares. Medical Properties Trust, Inc. has a 52 week low of $11.54 and a 52 week high of $15.74. The stock has a 50-day moving average price of $12.75 and a 200 day moving average price of $13.03. The stock has a market cap of $4.38 billion, a P/E ratio of 15.29 and a beta of 0.89.
Medical Properties Trust (NYSE:MPW) last released its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.32 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.32. The firm had revenue of $166.80 million during the quarter, compared to analyst estimates of $163.08 million. Medical Properties Trust had a net margin of 42.25% and a return on equity of 7.54%. The business’s revenue was up 32.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.32 EPS. On average, equities analysts forecast that Medical Properties Trust, Inc. will post $0.93 EPS for the current fiscal year.
A number of research analysts have weighed in on MPW shares. Deutsche Bank AG boosted their target price on shares of Medical Properties Trust from $13.50 to $15.00 and gave the stock a buy rating in a research report on Tuesday, July 4th. JMP Securities raised shares of Medical Properties Trust from a market perform rating to an outperform rating and set a $14.00 target price for the company in a research report on Monday, July 17th. They noted that the move was a valuation call. Jefferies Group LLC raised shares of Medical Properties Trust from a hold rating to a buy rating in a research report on Tuesday, July 4th. ValuEngine downgraded shares of Medical Properties Trust from a buy rating to a hold rating in a report on Friday, June 2nd. Finally, Royal Bank Of Canada restated a buy rating and set a $16.00 price objective on shares of Medical Properties Trust in a report on Monday, July 24th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the stock. The company presently has an average rating of Hold and an average target price of $14.20.
In other Medical Properties Trust news, CFO R Steven Hamner sold 85,000 shares of the business’s stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of $13.36, for a total value of $1,135,600.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.00% of the stock is owned by insiders.
About Medical Properties Trust
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
What are top analysts saying about Medical Properties Trust Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Medical Properties Trust Inc. and related companies.